- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
PRAXBIND - 50mg/ml - 2 x 50ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| V03AB37 | BioTech | Idarucizumab - 50mg/ml | 8853 | 93716/1 | PRAXBIND | 50mg/ml | 2 x 50ml | Injectable solution | Infusion/IV | Mersaco | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 279,544,870 L.L | 2.44 | E2 | Boehringer Ingelheim International GmbH | Germany | 2/5/2024 | 0 |